Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 8;8(1):395.
doi: 10.1038/s42003-025-07742-4.

Transcription factor ELF-1 protects against colitis by maintaining intestinal epithelium homeostasis

Affiliations

Transcription factor ELF-1 protects against colitis by maintaining intestinal epithelium homeostasis

Gege He et al. Commun Biol. .

Abstract

Inflammatory bowel disease (IBD) is a chronic, relapsing, and remitting disease characterized by chronic inflammation in the gastrointestinal tract. The exact etiology and pathogenesis of IBD remain elusive. Although ELF-1 has been known to be highly expressed in epithelial cells for past twenty years, little is known about its function in epithelial cells and epithelial-related IBD. Here, we demonstrated that ELF-1 deficiency in mouse lead to exacerbated DSS-induced colitis, marked by inflammation dominated by neutrophil infiltration and activation of IL-17 signaling pathways in various immune cells, including Th17, ILC3, γδT and NKT cells. Bone marrow transfer experiments confirmed ELF-1 deficiency in non-hematopoietic cells intrinsically worsened DSS-induced colitis. On one hand, ELF-1 deficiency enhanced the production of pro-inflammatory chemokines in colonic epithelial cells, leading to extensive infiltration of neutrophils and other immune cells into the colonic mucosal tissue. On the other hand, ELF-1 directly regulated the expression of the Rack1 gene in colonic epithelial tissue, which has been proved to play critical roles in maintaining intestinal homeostasis. Altogether, ELF-1 plays a protective role in colitis by maintaining intestinal epithelium homeostasis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. ELF-1 deficiency aggravated colitis.
A The body weight of WT and Elf-1−/− mice under normal condition and DSS treatment (n = 8). The survival rate (B) and DAI scores (C) of WT and Elf-1−/− mice in DSS-induced colitis (n = 8). Colon lengths (D) and spleen weight (E) of WT and Elf-1−/− mice in DSS-induced colitis (n = 8). H&E staining (F) and H&E scores (G) of colon tissues of WT and Elf-1−/− mice under normal conditions and DSS treatment (n = 8). H The mRNA levels of Il1b, Il6, Cxcl1, Cxcl2, Ccl2 and Ccl3 in colonic tissues of WT and Elf-1−/− mice in DSS-induced colitis (n = 3). Data are shown as mean ± SD, representing one of at least three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001.
Fig. 2
Fig. 2. ELF-1 deficiency causing an inflammation situation dominated by neutrophil infiltration in DSS colitis.
A UMAP plots and proportions of the identified cell types from the colonic tissues of DSS-treated WT and Elf-1−/− mice. B Dotplot of top 3 marker genes for the different cell subsets as indicated. C Percentages of CD11b+Ly6G+ neutrophils in colonic tissues of DSS-treated WT and Elf-1−/− mice (n = 3). GO (D) and KEGG (E) analyses of up-regulated DEGs in neutrophils of DSS-treated Elf-1−/− mice. F Expressions of representative genes of TNF and IL-17 signaling pathways in neutrophils of DSS-treated WT and Elf-1−/− mice. The intensity of expression is indicated as specified by the color legend. G UMAP plots and proportions of identified six subtypes in neutrophils of DSS-treated WT and Elf-1−/− mice. H Tracksplot of top marker genes for the subpopulations of neutrophil as indicated. I GO analysis of up-regulated DEGs in two identified subtypes of neutrophils (neutrophils5 and neutrophils6). J Differences in pathways scored by GSVA among different neutrophils subtypes.
Fig. 3
Fig. 3. IL-17 signaling pathway was markedly upregulated in DSS-treaeted Elf-1−/− mice.
A UMAP plots and proportions of the identified T cell types from the colonic tissues of DSS-treated WT and Elf-1−/− mice. B Heatmap of top marker genes for the subpopulations of T cells and ILCs group as indicated. C Percentages of CD4+IL-17+ Th17 cells and γδ T cells in colonic tissues of DSS-treated WT and Elf-1−/− mice (n = 3). KEGG (D) and GSEA (E) analyses of up-regulated DEGs in Th17, ILC3, NKT and γδT cells of DSS-treated Elf-1−/− mice. F Heatmap of representative genes of IL-17 signaling pathways in Th17, ILC3, NKT and γδT cells of DSS-treated WT and Elf-1−/− mice. The intensity of expression is indicated as specified by the color legend.
Fig. 4
Fig. 4. ELF-1 deficiency in non-hematopoietic cells intrinsically aggravates DSS induced colitis.
A The schematic diagram of construction of bone marrow chimera. The body weight (B) and DAI scores (C) of irradiated WT and Elf-1−/− mice transferred with WT or Elf-1−/− bone marrow in DSS-induced colitis (n = 8). Colon lengths (D) and spleen weight (E) of irradiated WT and Elf-1−/− mice transferred with WT or Elf-1−/− bone marrow in DSS-induced colitis (n = 8). F H&E staining and H&E scores of irradiated WT and Elf-1−/− mice transferred with WT or Elf-1−/− bone marrow in DSS-induced colitis (n = 8). Data are shown as mean ± SD, representing one of at least three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001.
Fig. 5
Fig. 5. ELF-1 deficiency enhanced expression of chemokines in colonic epithelial cells in DSS-induced colitis.
A UMAP plots and proportions of the identified subtypes in colonic epithelial cells from the colonic tissues of DSS-treated WT and Elf-1−/− mice. B Tracksplot of top 3 marker genes for the subpopulations of colonic epithelial cells as indicated. C Ligand‒receptor interaction between colonic epithelial cell and immune cell types. D KEGG analysis of up-regulated DEGs in colonic epithelial cells of DSS-treated Elf-1−/− mice. E Expressions of representative genes of cytokine-cytokine receptor interaction signaling pathways in colonic epithelial cells of DSS-treated WT and Elf-1−/− mice. F The mRNA levels of Cxcl13, Cxcl2, Cxcl1, Ccl2, Ccl11, Ccl3 and Il1b in colonic epithelial tissues of normal and DSS-treated WT and Elf-1−/− mice (n = 4). Data are shown as mean ± SD, representing one of at least three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001.
Fig. 6
Fig. 6. ELF-1 directly regulates Rack1 expression in DSS colitis.
A Distribution of ELF-1 binding sites from ChIP-Seq analysis of colonic tissues of WT mice. B KEGG pathway enrichment analysis of ELF-1 binding genes (binding peaks located in gene promoter regions). C Venn diagram showing overlapping gene between ELF-1 binding genes with down regulated DEGs in colonic epithelial cells of DSS-treated Elf-1−/− mice. D ChIP-seq peak for ELF-1 binding site in Rack1 gene. E Top 2 predicted ELF-1 binding motifs in Rack1 gene promoter with the most significant P values. F Rack1 expressions in colonic epithelial cells of DSS-treated WT and Elf-1−/− mice. G Rack1 expressions in colonic epithelial tissues of normal and DSS-treated WT and Elf-1−/− mice (n = 4). Data are shown as mean ± SD, representing one of at least three independent experiments. **P < 0.01.

References

    1. de Souza, H. S. P., Fiocchi, C. & Iliopoulos, D. The IBD interactome: an integrated view of aetiology, pathogenesis and therapy. Nat. Rev. Gastroenterol. Hepatol.14, 739–749 (2017). - PubMed
    1. Flynn, S. & Eisenstein, S. Inflammatory Bowel Disease Presentation and Diagnosis. Surg. Clin. North Am.99, 1051–1062 (2019). - PubMed
    1. de Souza, H. S. & Fiocchi, C. Immunopathogenesis of IBD: current state of the art. Nat. Rev. Gastroenterol. Hepatol.13, 13–27 (2016). - PubMed
    1. Mayer, L. Evolving paradigms in the pathogenesis of IBD. J. Gastroenterol.45, 9–16 (2010). - PubMed
    1. Parikh, K. et al. Colonic epithelial cell diversity in health and inflammatory bowel disease. Nature567, 49–4 (2019). - PubMed

LinkOut - more resources